Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
The DOI matches its Crossref record; 109 of the 110 references it cites were found in a registry or an index.
Abstract
Abstinence from alcohol has been the prevailing treatment goal for individuals with alcohol dependence (AD) within the context of specialty alcohol treatment. Yet, alcohol use has been conceptualized as existing on a continuum. Importantly, most people who meet criteria for AD and could benefit from treatment never receive treatment. About half of these individuals do not seek treatment because they report a desire to continue drinking. To increase acceptability of treatment, reductions in alcohol consumption have been examined as alternative outcomes in treatment trials for AD. The current study reviews data which indicate that long-term reduction in alcohol consumption among patients with AD is possible. Controlled studies have tested reduced alcohol consumption and show sustained improvements in drinking reductions for many patients following behavioral treatments and pharmacotherapy. Evidence-based treatment guidelines and medicines development guidance authorities have taken note of these developments and accept “intermediate harm reduction” (European Medicines Agency) or “low-risk drinking limits” (US Federal Drug Administration) as optional trial endpoints. In conclusion, while abstinence remains the safest treatment goal for individuals with AD, evidence supports that reduced drinking approaches may be an important extension in the treatment of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60746-7 · Cited by 3,870
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Naltrexone and Coping Skills Therapy for Alcohol Dependence: A Controlled Study
O'Malley, S. S. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110045007 · Cited by 1,487
Treatment gap in mental health care.
Abramowitz, M. Z., Greenberg, D., & Levav, I. (2008) · PubMed · Cited by 1,483
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Rehm, J., Baliunas, D., Borges, G. L. G., Graham, K., Irving, H., Kehoe, T., Parry, C. D., Patra, J., Popova, S., Poznyak, V., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02899.x · Cited by 1,174
Di Castelnuovo, A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.22.2437 · Cited by 930
Jonas, D. E., Amick, H. R., Feltner, C., Bobashev, G., Thomas, K., Wines, R., Kim, M. M., Shanahan, E., Gass, C. E., Rowe, C. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.3628 · Cited by 923
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Alcohol as a Risk Factor for Type 2 Diabetes
Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009) · Diabetes Care · doi:10.2337/dc09-0227 · Cited by 703
Stockwell, T., Zhao, J., Panwar, S., Roemer, A., Naimi, T., & Chikritzhs, T. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.185 · Cited by 654
Garbutt, J. C., Kranzler, H. R., O’Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., Loewy, J. W., Ehrich, E. W., & Vivitrex Study Group, F. T. (2005) · JAMA · doi:10.1001/jama.293.13.1617 · Cited by 635
The Natural History of Alcoholism
Taylor, J. R., & Helzer, J. E. (1983) · The Biology of Alcoholism · doi:10.1007/978-1-4684-4274-8_2 · Cited by 622
Naltrexone in the Treatment of Alcohol Dependence
Krystal, J. H., Cramer, J. A., Krol, W. F., Kirk, G. F., & Rosenheck, R. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011127 · Cited by 618
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Harm reduction approaches to alcohol use
Marlatt, G. A., & Witkiewitz, K. (2002) · Addictive Behaviors · doi:10.1016/s0306-4603(02)00294-0 · Cited by 491
Self-citationMann, K., Bladström, A., Torup, L., Gual, A., & van den Brink, W. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.020 · Cited by 484
Self-citationCohen, E., Feinn, R., Arias, A., & Kranzler, H. R. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.06.008 · Cited by 467
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
Gual, A., He, Y., Torup, L., van den Brink, W., & Mann, K. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.02.006 · Cited by 407
Self-citationAlteration of ethanol self-administration by naltrexone
Altshuler, H. L., Phillips, P. E., & Feinhandler, D. A. (1980) · Life Sciences · doi:10.1016/0024-3205(80)90257-x · Cited by 397
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366
Governmental standard drink definitions and low‐risk alcohol consumption guidelines in 37 countries
Kalinowski, A., & Humphreys, K. (2016) · Addiction · doi:10.1111/add.13341 · Cited by 360
Review of the effectiveness of treatment for alcohol problems.
Raistrick, D., Heather, N., & Godfrey, C. (2006) · Cited by 348
[Alcohol-related morbidity and mortality].
Becker, U., & Tolstrup, J. S. (2021) · PubMed · Cited by 344
A 60-year follow up of alcoholic men
Vaillant, G. E. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00422.x · Cited by 340
Rösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300
Litten, R. Z., Ryan, M. L., Fertig, J. B., Falk, D. E., Johnson, B., Dunn, K. E., Green, A. I., Pettinati, H. M., Ciraulo, D. A., Sarid-Segal, O., et al. (2013) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31829623f4 · Cited by 287
Psychoactive drugs and harm reduction: from faith to science.
Heather, N., WODAK, A. D., Nadelmann, E. A., & O'Hare, P. A. (1993) · Cited by 265
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867.pub2 · Cited by 265
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Dawson, D. A., Goldstein, R. B., & Grant, B. F. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00536.x · Cited by 261
Roerecke, M., & Rehm, J. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03780.x · Cited by 249
Sanchez-Craig, M., Annis, H. M., Bronet, A. R., & MacDonald, K. R. (1984) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.52.3.390 · Cited by 226
Heinälä, P., Alho, H., Kiianmaa, K., Lönnqvist, J., Kuoppasalmi, K., & Sinclair, J. D. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200106000-00006 · Cited by 226
Update on harm-reduction policy and intervention research
Marlatt, G. A., & Witkiewitz, K. (2010) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.121208.131438 · Cited by 220
Self-citationKnott, C. S., Coombs, N., Stamatakis, E., & Biddulph, J. P. (2015) · BMJ · doi:10.1136/bmj.h384 · Cited by 209
A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders
Blodgett, J. C., Del Re, A. C., Maisel, N. C., & Finney, J. W. (2014) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12411 · Cited by 188
Alcoholics treated by individualized behavior therapy: One year treatment outcome
Sobell, M. B., & Sobell, L. C. (1973) · Behaviour Research and Therapy · doi:10.1016/0005-7967(73)90118-6 · Cited by 184
Topiramate Treatment for Heavy Drinkers: Moderation by a GRIK1 Polymorphism
Kranzler, H. R., Covault, J., Feinn, R., Armeli, S., Tennen, H., Arias, A. J., Gelernter, J., Pond, T., Oncken, C., & Kampman, K. M. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13081014 · Cited by 184
Harm reduction -a systematic review on effects of alcohol reduction on physical and mental symptoms
Charlet, K., & Heinz, A. (2017) · Addiction Biology · doi:10.1111/adb.12414 · Cited by 183
Sinclair, J. D. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.1.2 · Cited by 174
Zhao, J., Stockwell, T., Roemer, A., Naimi, T., & Chikritzhs, T. (2017) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2017.78.375 · Cited by 173
The Status of Naltrexone in the Treatment of Alcohol Dependence: Specific Effects on Heavy Drinking
Pettinati, H. M., O'Brien, C. P., Rabinowitz, A. R., Wortman, S. P., Oslin, D. W., Kampman, K. M., & Dackis, C. A. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245566.52401.20 · Cited by 169
Kranzler, H. R., Wesson, D. R., Billot, L., & DrugAbuse Sciences Naltrexone Depot Study Group (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000130804.08397.29 · Cited by 169
Witkiewitz, K., Hallgren, K. A., Kranzler, H. R., Mann, K. F., Hasin, D. S., Falk, D. E., Litten, R. Z., O'Malley, S. S., & Anton, R. F. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13272 · Cited by 154
Self-citationEpidemiology and alcohol policy in Europe
Rehm, J., Zatonksi, W., Taylor, B., & Anderson, P. (2011) · Addiction · doi:10.1111/j.1360-0443.2010.03326.x · Cited by 148
Guidelines for the Treatment of Alcohol Problems: (674042010-001)
(2009) · PsycEXTRA Dataset · doi:10.1037/e674042010-001 · Cited by 142
Hasin, D. S., Wall, M., Witkiewitz, K., Kranzler, H. R., Falk, D., Litten, R., Mann, K., O'Malley, S. S., Scodes, J., Robinson, R. L., et al. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30130-x · Cited by 140
Self-citationPharmacotherapy for smoking cessation: pharmacological principles and clinical practice
Aubin, H., Luquiens, A., & Berlin, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12116 · Cited by 138
Self-citationInitial Preference for Drinking Goal in the Treatment of Alcohol Problems: II. Treatment Outcomes
Adamson, S. J., Heather, N., Morton, V., Raistrick, D., & on behalf of the UKATT Research Team (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq005 · Cited by 135
Karhuvaara, S., Simojoki, K., Virta, A., Rosberg, M., Löyttyniemi, E., Nurminen, T., Kallio, A., & Mäkelä, R. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00401.x · Cited by 128
Pharmacotherapy of Alcohol Use Disorders: Seventy-Five Years of Progress
Zindel, L. R., & Kranzler, H. R. (2014) · Journal of Studies on Alcohol and Drugs, Supplement · doi:10.15288/jsads.2014.75.79 · Cited by 128
van den Brink, W., Sørensen, P., Torup, L., Mann, K., Gual, A., & for the SENSE Study Group (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114527362 · Cited by 128
Self-citationReduction of drinking in problem drinkers and all-cause mortality
Rehm, J., & Roerecke, M. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/agt021 · Cited by 122
Rolland, B., Paille, F., Gillet, C., Rigaud, A., Moirand, R., Dano, C., Dematteis, M., Mann, K., & Aubin, H. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12489 · Cited by 120
Self-citationBehavioral self-control training for problem drinkers: A meta-analysis of randomized control studies
Walters, G. D. (2000) · Behavior Therapy · doi:10.1016/s0005-7894(00)80008-8 · Cited by 116
Mann, K. F., Torup, L., Sørensen, P. S., Gual, A., Swift, R. M., Walker, B. M., & van den Brink, W. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.10.008 · Cited by 110
Self-citationReduced-risk drinking as a viable treatment goal in problematic alcohol use and alcohol dependence
van Amsterdam, J., & van den Brink, W. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113495320 · Cited by 109
The long‐term course of alcoholism, 5, 10 and 16 years after treatment
Mann, K., Schäfer, D. R., Längle, G., Ackermann, K., & Croissant, B. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01065.x · Cited by 109
Self-citationPharmacotherapy for alcohol dependence: status of current treatments
Franck, J., & Jayaram-Lindström, N. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.005 · Cited by 107
Varenicline for Treatment of Alcohol Dependence: A Randomized, Placebo‐Controlled Trial
de Bejczy, A., Löf, E., Walther, L., Guterstam, J., Hammarberg, A., Asanovska, G., Franck, J., Isaksson, A., & Söderpalm, B. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12854 · Cited by 105
Palpacuer, C., Laviolle, B., Boussageon, R., Reymann, J. M., Bellissant, E., & Naudet, F. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001924 · Cited by 102
Reduced-risk drinking as a treatment goal: what clinicians need to know
Sobczak, J. A. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00210-0 · Cited by 95
Heather, N., Adamson, S. J., Raistrick, D., Slegg, G. P., & on behalf of the UKATT Research Team (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp096 · Cited by 94
Acceptance of non-abstinence goals by addiction professionals in the United States.
Davis, A. K., & Rosenberg, H. (2012) · Psychology of Addictive Behaviors · doi:10.1037/a0030563 · Cited by 94
Mann, K., Kiefer, F., Smolka, M., Gann, H., Wellek, S., Heinz, A., & and the PREDICT Study research team (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00884.x · Cited by 93
Self-citationDawson, D. A., Li, T.-K., Chou, S. P., & Grant, B. F. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn094 · Cited by 91
Recommendations for the Design and Analysis of Treatment Trials for Alcohol Use Disorders
Witkiewitz, K., Finney, J. W., Harris, A. H. S., Kivlahan, D. R., & Kranzler, H. R. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12800 · Cited by 81
Self-citationAlcohol consumption and symptoms as predictors for relapse of DSM-5 alcohol use disorder
Tuithof, M., ten Have, M., van den Brink, W., Vollebergh, W., & de Graaf, R. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.035 · Cited by 73
Shield, K. D., Gmel, G., Gmel, G., Mäkelä, P., Probst, C., Room, R., & Rehm, J. (2017) · Addiction · doi:10.1111/add.13827 · Cited by 71
The effects of drinking goal on treatment outcome for alcoholism.
Bujarski, S., O'Malley, S. S., Lunny, K., & Ray, L. A. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0030886 · Cited by 70
Treatment Seeking for Alcohol Use Disorders: Treatment Gap or Adequate Self-Selection?
Tuithof, M., ten Have, M., van den Brink, W., Vollebergh, W., & de Graaf, R. (2016) · European Addiction Research · doi:10.1159/000446822 · Cited by 69
Targeted naltrexone treatment of early problem drinkers
Kranzler, H. R., Tennen, H. A., Penta, C., & Bohn, M. J. (1997) · Addictive Behaviors · doi:10.1016/s0306-4603(96)00064-0 · Cited by 67
Kerr, W. C., Greenfield, T. K., Bond, J. C., Ye, Y., & Rehm, J. T. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr147 · Cited by 65
Current pharmacological treatment approaches for alcohol dependence
Müller, C. A., Geisel, O., Banas, R., & Heinz, A. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.876008 · Cited by 64
Varenicline in the Treatment of Alcohol Use Disorders
Erwin, B. L., & Slaton, R. M. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014545806 · Cited by 63
Lapses following Alcohol Treatment: Modeling the Falls From the Wagon
Witkiewitz, K. (2008) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2008.69.594 · Cited by 60
Self-citationAubin, H., & Daeppen, J. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.04.025 · Cited by 58
Self-citationLuquiens, A., Reynaud, M., Falissard, B., & Aubin, H. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.08.012 · Cited by 57
Self-citationEffect of Extended‐Release Naltrexone (XR‐NTX) on Quality of Life in Alcohol‐Dependent Patients
Pettinati, H. M., Gastfriend, D. R., Dong, Q., Kranzler, H. R., & O’Malley, S. S. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00843.x · Cited by 53
Moderate Drinking in the First Year After Treatment as a Predictor of Three-Year Outcomes
Maisto, S. A., Clifford, P. R., Stout, R. L., & Davis, C. M. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.419 · Cited by 50
Luquiens, A., Whalley, D., Crawford, S. R., Laramée, P., Doward, L. C., Price, M. A., Hawken, N. A., Dorey, J., Owens, L., Llorca, P., et al. (2014) · Quality of Life Research · doi:10.1007/s11136-014-0865-7 · Cited by 50
Self-citationChanges of drinking goals in a two-year out-patient alcoholic treatment program
Öjehagen, A., & Berglund, M. (1989) · Addictive Behaviors · doi:10.1016/0306-4603(89)90011-7 · Cited by 48
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial
Diehl, A., Nakovics, H., Croissant, B., Smolka, M. N., Batra, A., & Mann, K. (2006) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp44614 · Cited by 47
Self-citationFitzgerald, N., Angus, K., Elders, A., de Andrade, M., Raistrick, D., Heather, N., & McCambridge, J. (2016) · Addiction · doi:10.1111/add.13438 · Cited by 45
German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders
Mann, K. F., Batra, A., Fauth‐Bühler, M., Hoch, E., & and the Guideline Group (2017) · European Addiction Research · doi:10.1159/000455841 · Cited by 42
Self-citationClinical Relevance of As-Needed Treatment with Nalmefene in Alcohol-Dependent Patients
Aubin, H., Reimer, J., Nutt, D., Bladström, A., Torup, L., François, C., & Chick, J. (2015) · European Addiction Research · doi:10.1159/000371547 · Cited by 40
Self-citationGuidelines for the Reporting of Treatment Trials for Alcohol Use Disorders
Witkiewitz, K., Finney, J. W., Harris, A. H. S., Kivlahan, D. R., & Kranzler, H. R. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12797 · Cited by 37
Self-citationMann, K. F., Ackermann, K., Diehl, A., Ebert, D., Mundle, G., Nakovics, H., Reker, T., Richter, G., Schmidt, L., Drießen, M., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0243-9 · Cited by 36
Self-citationAlcohol Use Trajectories Among Non–Treatment-Seeking Heavy Drinkers
Witkiewitz, K. A., Dearing, R. L., & Maisto, S. A. (2014) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2014.75.415 · Cited by 35
Self-citationLeitlinienorientierte Behandlung alkoholbezogener Störungen
Mann, K. F., Hoch, E., Batra, A., Bonnet, U., Günthner, A., Reymann, G., Soyka, M., Wodarz, N., & Schäfer, M. (2015) · Der Nervenarzt · doi:10.1007/s00115-015-0022-8 · Cited by 35
Self-citationWitkiewitz, K. A., Wilson, A. D., Pearson, M. R., Hallgren, K. A., Falk, D. E., Litten, R. Z., Kranzler, H. R., Mann, K. F., Hasin, D. S., O’Malley, S. S., et al. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13371 · Cited by 34
Self-citationFrançois, C., Rahhali, N., Chalem, Y., Sørensen, P. S., Luquiens, A., & Aubin, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129289 · Cited by 32
Self-citationRe, A. C. D., Maisel, N. C., Blodgett, J. C., & Finney, J. W. (2013) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12067 · Cited by 32
Kline‐Simon, A. H., Litten, R. Z., Weisner, C. M., & Falk, D. E. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13334 · Cited by 32
Miquel, L., Gual, A., Vela, E., Lligoña, A., Bustins, M., Colom, J., & Rehm, J. T. (2016) · Alcohol and Alcoholism · doi:10.1093/alcalc/agw075 · Cited by 25
Harm Reduction as “Continuum Care” in Alcohol Abuse Disorder
Maremmani, I., Cibin, M., Pani, P., Rossi, A., & Turchetti, G. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph121114828 · Cited by 21
It is time for low‐risk drinking goals to come out of the closet
Sobell, M. B., & Sobell, L. C. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03509.x · Cited by 18
Psychosocial determinants of recovery in depression
Fava, G. A., & Visani, D. (2008) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2008.10.4/gafava · Cited by 18
A realist review of brief interventions for alcohol misuse delivered in emergency departments
Davey, C. J., Landy, M. S. H., Pecora, A., Quintero, D., & McShane, K. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0024-4 · Cited by 14
Midlöv, P., Calling, S., Memon, A. A., Sundquist, J., Sundquist, K., & Johansson, S. (2015) · BMC Public Health · doi:10.1186/s12889-016-2700-2 · Cited by 14
Feinn, R., Curtis, B. J., & Kranzler, H. R. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10053 · Cited by 14
Rolland, B., Mann, K. F., Paillé, F., & Aubin, H. (2015) · Addiction · doi:10.1111/add.12997 · Cited by 9
Self-citationNordstrom, G., Berglund, M., & Frank, A. (2004) · European Addiction Research · doi:10.1159/000077701 · Cited by 7
Bramness, J. G., Mann, K. F., & Wurst, F. M. (2016) · European Addiction Research · doi:10.1159/000447965 · Cited by 7
Self-citationLaramée, P., Millier, A., Rahhali, N., Cristeau, O., Aballéa, S., François, C., Chalem, Y., Toumi, M., & Rehm, J. T. (2016) · Applied Health Economics and Health Policy · doi:10.1007/s40258-016-0248-z · Cited by 4
Feeding Two Birds with One Scone: The Case of Varenicline
Aubin, H., & Luquiens, A. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12907 · Cited by 3
Self-citation
Research works printed but not linked: 1
- 10.1001/jama.2014.3628 · DOI · Paper page
Cited by
Alcohol use disorder relapse factors: A systematic review.
Sliedrecht, W., de Waart, R., Witkiewitz, K., & Roozen, H. G. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.05.038 · Cited by 358
Self-citationAlcohol use disorders and the heart
Day, E., & Rudd, J. H. F. (2019) · Addiction · doi:10.1111/add.14703 · Cited by 183
Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Knox, J., Hasin, D. S., Larson, F. R. R., & Kranzler, H. R. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30213-5 · Cited by 141
Witkiewitz, K. A., Kranzler, H. R., Hallgren, K. A., O’Malley, S. S., Falk, D. E., Litten, R. Z., Hasin, D. S., Mann, K. F., & Anton, R. F. (2018) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13897 · Cited by 151
“Extending treatment options to target reductions in drinking, rather than complete abstinence, could expand the reach of alcohol treatment and have an important impact on public health (Mann et al., 2017; Maremmani et al., 2015; van Amsterdam and van den Brink, 2013).”
Self-citationExpanding the continuum of substance use disorder treatment: Nonabstinence approaches
Paquette, C. E., Daughters, S. B., & Witkiewitz, K. A. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102110 · Cited by 164
Self-citation
Metadata
- Authors
- Mann, K., Aubin, H.-J., & Witkiewitz, K.
- Affiliations
- Heidelberg University (DE)
- Université Paris-Sud (FR)
- University of New Mexico (US)
- Venue
- European Addiction Research
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 23
- Issue
- 5
- Pages
- 219-230
- ISSN
- 1022-6877 (ISSN-L)
- 1421-9891
- OpenAlex
- W2759499582
- Cited by
- 93
- References
- 110
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 11 · 2023: 12 · 2022: 10 · 2021: 13 · 2020: 12 · 2019: 14 · 2018: 6 · 2017: 1
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
- Locations
- European Addiction Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- alcoholism, harm reduction, abstinence, treatment outcomes, behavior therapy, pharmacotherapy, treatment acceptability, treatment-seeking behavior
- MeSH terms
- Alcohol Drinking, Alcoholism, Female, Humans, Male, Behavior, Addictive, Treatment Outcome, Harm Reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.